Search Results - "Vajdic, Caitlin"
-
1
Risk Factors for CMV Infection, Including HLA Disparity and Ptcy Transplant in the Era of Letermovir Prophylaxis
Published in Blood (02-11-2023)“…Reports suggest that post-transplant cyclophosphamide (PTCy) for haploidentical and HLA-matched sibling donor allogeneic stem cell transplant (allo-SCT) is…”
Get full text
Journal Article -
2
Addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma
Published in Journal of clinical oncology (01-06-2023)“…e18732 Background: Autologous stem cell transplant (ASCT) is standard therapy for patients (pts) with multiple myeloma (MM), yet the risks of such treatment…”
Get full text
Journal Article -
3
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis
Published in Annals of hematology (01-03-2023)“…Full donor T-cell chimerism (FDTCC) after allogeneic stem cell transplant (allo-SCT) has been associated with improved outcomes in hematologic malignancy. We…”
Get full text
Journal Article -
4
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation
Published in Leukemia research (01-08-2024)“…Primary graft failure (PGF) and multi-lineage cytopenia (MLC) increase the risk of nonrelapse mortality in allogeneic hematopoietic cell transplants (HCT). We…”
Get full text
Journal Article -
5
-
6
-
7
Bloodstream Infection in Allogeneic Transplant Patients Treated with Post-Transplant Cyclophosphamide
Published in Transplantation and cellular therapy (01-02-2024)“…Bloodstream infection (BSI) is one of the most frequent complications in allogeneic hematopoietic cell transplant (allo-HCT), with a reported incidence of…”
Get full text
Journal Article -
8
The Impact of Steroid Use on the Outcome of the Ptcy Transplant
Published in Transplantation and cellular therapy (01-02-2024)“…Steroids are commonly used to treat graft versus host disease (GVHD) in allogeneic hematopoietic cell transplant (allo-HCT). Although higher doses of steroids…”
Get full text
Journal Article -
9
560 - Identifying Factors Affecting the Outcome after DLI: How to Utilize GVL Effectively
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
10
Identifying Factors Affecting the Outcome after DLI: How to Utilize GVL Effectively
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
11
Low Dose Total Body Irradiation (TBI) Plus Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease (GVHD) Prophylaxis Facilitates Early Chimerism Achievement and a Tendency Towards Improved Disease-Free Survival in Alternative Donor Allogeneic Stem Cell Transplant
Published in Transplantation and cellular therapy (01-03-2021)Get full text
Journal Article -
12